Search results for "Epidermolysis Bullosa"

showing 10 items of 22 documents

Epidermolysis Bullosa Simplex-Type Mutations Alter the Dynamics of the Keratin Cytoskeleton and Reveal a Contribution of Actin to the Transport of Ke…

2003

Dominant keratin mutations cause epidermolysis bullosa simplex by transforming keratin (K) filaments into aggregates. As a first step toward understanding the properties of mutant keratins in vivo, we stably transfected epithelial cells with an enhanced yellow fluorescent protein-tagged K14R125C mutant. K14R125C became localized as aggregates in the cell periphery and incorporated into perinuclear keratin filaments. Unexpectedly, keratin aggregates were in dynamic equilibrium with soluble subunits at a half-life time of <15 min, whereas filaments were extremely static. Therefore, this dominant-negative mutation acts by altering cytoskeletal dynamics and solubility. Unlike previously post…

KeratinocytesMutantmacromolecular substancesBiologyEpidermolysis bullosa simplexMicrotubuleKeratinmedicineHumansRNA Small InterferingCytoskeletonMolecular BiologyCells CulturedCytoskeletonActinchemistry.chemical_classificationintegumentary systemBiological TransportArticlesCell BiologyKeratin 6Amedicine.diseaseMolecular biologyActinsRecombinant ProteinsCell biologyKeratin 5chemistryEpidermolysis Bullosa SimplexMutationKeratinsMolecular Biology of the Cell
researchProduct

Recognizable neonatal clinical features of aplasia cutis congenita

2020

Abstract Background Aplasia cutis congenita (ACC), classified in nine groups, is likely to be underreported, since milder isolated lesions in wellbeing newborns could often be undetected, and solitary lesions in the context of polymalformative syndromes could not always be reported. Regardless of form and cause, therapeutic options have in common the aim to restore the deficient mechanical and immunological cutaneous protection and to limit the risk of fluid leakage or rupture of the exposed organs. We aimed to review our institutional prevalence, comorbidities, treatment and outcome of newborns with ACC. Methods We conducted a retrospective study including all newborns affected by ACC and …

Male0301 basic medicinePediatricsmedicine.medical_specialtyMeningomyeloceleAbdominal compartment syndromeContext (language use)030105 genetics & heredityAplasia cutis congenita03 medical and health sciencesEctodermal DysplasiaPrevalenceHumansMedicineBody Weights and MeasuresRetrospective StudiesPregnancybusiness.industryResearchAbdominal wall defectInfant Newbornlcsh:RJ1-570Gestational agelcsh:PediatricsRetrospective cohort studyPrognosismedicine.diseaseSurvival RateAbdominal wall defectRetrospective study030104 developmental biologyItalyScalp defectFemaleApgar scoreJunctional epidermolysis bullosamedicine.symptombusiness
researchProduct

Dystrophic epidermolysis bullosa: oral findings and problems.

2006

Dystrophic epidermolysis bullosa (DEB) is one of the three major types of epidermolysis bullosa (EB), an inherited cutaneous disease with blister formation following minor trauma. A subtype of DEB is recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens type (RDEB-HS), where marked scarring leads to deformities of extremities. In RDEB-HS the mucous membranes may also be involved and form adhesions with ankyloglossia and microstomia. Oral hygiene is difficult. A 7-year-old boy with RDEB-HS was brought to the Johannes Gutenberg University dental clinic with dental pain. He had multiple carious lesions, poor oral hygiene and gingivitis. Because he was noncompliant and had microstomia, …

MalePit and Fissure SealantsToothbrushingmedicine.medical_specialtyMouthwashesDiseaseDental CariesOral hygieneGingivitismedicineHumansChildDental Restoration PermanentGeneral Dentistrybusiness.industryMicrostomiaDental Care for DisabledChlorhexidineChlorhexidineEpidermolysis bullosa dystrophicamedicine.diseaseDental Care for DisabledDermatologyEpidermolysis Bullosa Dystrophicastomatognathic diseasesTooth ExtractionAnti-Infective Agents LocalEpidermolysis bullosamedicine.symptombusinessmedicine.drugFollow-Up StudiesSpecial care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
researchProduct

Oxidative stress and mitochondrial dysfunction in Kindler syndrome

2014

This is an Open Access article distributed under the terms of the Creative Commons Attribution License.-- et al.

Premature agingMaleKeratinocytesAdolescentComputingMilieux_LEGALASPECTSOFCOMPUTINGMitochondrionmedicine.disease_causePathogenesisKindler syndrome03 medical and health scienceschemistry.chemical_compound0302 clinical medicineBlistermedicineHumansGenetics(clinical)Pharmacology (medical)Photosensitivity DisordersGenodermatosisChildGenetics (clinical)Cells CulturedPeriodontal Diseases030304 developmental biologyAged 80 and overMedicine(all)0303 health sciencesintegumentary systemResearchGeneral MedicineGlutathioneMiddle Agedmedicine.diseaseMalondialdehydeMolecular biology3. Good healthMitochondriaOxidative StresschemistryOxidative stress030220 oncology & carcinogenesisChild PreschoolFemaleSkin cancerEpidermolysis BullosaKindlin1Oxidative stressOrphanet Journal of Rare Diseases
researchProduct

Focal adhesions are hotspots for keratin filament precursor formation

2006

Recent studies showed that keratin filament (KF) formation originates primarily from sites close to the actin-rich cell cortex. To further characterize these sites, we performed multicolor fluorescence imaging of living cells and found drastically increased KF assembly in regions of elevated actin turnover, i.e., in lamellipodia. Abundant KF precursors (KFPs) appeared within these areas at the distal tips of actin stress fibers, moving alongside the stress fibers until their integration into the peripheral KF network. The earliest KFPs were detected next to actin-anchoring focal adhesions (FAs) and were only seen after the establishment of FAs in emerging lamellipodia. Tight spatiotemporal …

TalinKeratin 14Intermediate Filamentsmacromolecular substancesBiologyTransfectionKeratin 18Cell LineFocal adhesionMiceReportStress FibersCell cortexMetalloproteinsAnimalsHumansRNA AntisensePseudopodiaCytoskeletonActinResearch ArticlesCell Line TransformedFocal AdhesionsKeratin FilamentKeratin-18Keratin-14Cell BiologyBridged Bicyclo Compounds HeterocyclicActinsZyxinCell biologyProtein TransportThiazolesBiochemistryEpidermolysis Bullosa SimplexMutationKeratinsThiazolidinesMarine ToxinsLamellipodiumPaxillinThe Journal of Cell Biology
researchProduct

Control Of Organ Transplant-Associated Graft-versus-Host Disease By Activated Host Lymphocyte Infusions

2004

Background Prolonged persistence of donor-derived T cells after organ transplantation has been proposed to improve long-term allograft survival. However, surviving transplant-derived T cells are also able to mediate devastating graft-versus-host disease (GvHD). Currently, GvHD after organ transplantation is usually refractory to conventional therapy and the disease outcome fatal. Methods Graft-reactive host T cells were generated ex vivo from a patient suffering from a severe and refractory liver-transplant-associated GvHD. To control GvHD, activated alloreactive host T cells were repetitively retransferred into the patient (activated host lymphocyte infusion [aHLI]). Results Adoptive trans…

medicine.medical_specialtyAdoptive cell transferLymphocytemedicine.medical_treatmentGraft vs Host Diseasechemical and pharmacologic phenomenaLymphocyte ActivationImmunotherapy AdoptiveSeverity of Illness IndexOrgan transplantationBlood Transfusion AutologousmedicineHumansAgedTransplantationbusiness.industryImmunotherapymedicine.diseaseAdoptive TransferLiver TransplantationTransplantationsurgical procedures operativeGraft-versus-host diseasemedicine.anatomical_structureLymphocyte TransfusionImmunologyFemaleStem cellEpidermolysis BullosabusinessEx vivoTransplantation
researchProduct

Pruriginous Lesions in a Young Girl: Answer.

2018

medicine.medical_specialtyCollagen Type VIIbusiness.industrymedia_common.quotation_subjectPruritusMEDLINEDermatologyGeneral MedicineDermatologyPathology and Forensic MedicineEpidermolysis Bullosa Dystrophica030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisMutation (genetic algorithm)MutationMedicineHumansFemaleGirlbusinessChildmedia_commonThe American Journal of dermatopathology
researchProduct

Implants in patients with oral manifestations of autoimmune or muco-cutaneous diseases – A systematic review

2018

Background To give an overview on implant survival rates in patients with oral manifestations of systemic autoimmune (oral Lichen planus (oLp), Pemphigus (Pe)), muco-cutaneous (Epidermolysis bullosa (EB)), autoimmune multisystemic rheumatic diseases (Sjögren´s syndrome (SjS), systemic Lupus erythematosus (sLE), or systemic Sclerosis (sSc)). Material and Methods Systematic literature review (PubMed/Medline, Embase) using MESH and search term combinations, published between 1980 and August 2018 in English language reporting on dental implant-prosthetic rehabilitation of patients with oLp, Pe, EB, SjS, sLE, sSc, study design, age, gender, follow-up period (≥ 12 months), implant survival rate. …

medicine.medical_specialtyDatabases FactualReviewScleroderma03 medical and health sciences0302 clinical medicinemedicineHumansLupus Erythematosus SystemicDental Restoration Failureskin and connective tissue diseasesGeneral DentistrySurvival rateDental ImplantsScleroderma SystemicLupus erythematosusintegumentary systembusiness.industryDental prosthesis030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Medically compromised patients in Dentistrymedicine.diseaseDermatologystomatognathic diseasesPemphigusSjogren's SyndromeTreatment OutcomeOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryOral lichen planusDental Prosthesis Implant-SupportedImplantEpidermolysis bullosaEpidermolysis BullosaMouth DiseasesbusinessPemphigusLichen Planus OralMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Congenital myopathy and epidermolysis bullosa due to PLEC variant

2021

Abstract We report on an adult Turkish patient with mild myopathy with a fiber-type disproportion and mitochondrial disorganization caused by genetic variants in the plectin gene (PLEC). Molecular genetic panel testing revealed two homozygous variants in PLEC (NM_000445.4): c.8306C>G (p.Pro2769Arg) and c.7506 + 5C>G (p. ?) that were classified as variants of unknown significance (class 3) following ACMG guidelines for variant classification in genetic diagnostics. A thorough reassessment of the patient revealed mild skin blistering (epidermolysis bullosa simplex, EBS). This illustrates the importance of deep phenotyping of neuromuscular patients.

medicine.medical_specialtybusiness.industryGenetic variantsmedicine.diseaseDermatologyCongenital myopathyPlectin GeneEpidermolysis bullosa simplexUnknown SignificanceNeurologySkin blisteringPediatrics Perinatology and Child HealthmedicineNeurology (clinical)Epidermolysis bullosamedicine.symptomMyopathybusinessGenetics (clinical)Neuromuscular Disorders
researchProduct

Epidermólisis ampollosa hereditaria: serie de casos

2021

medicine.medical_specialtybusiness.industryRL1-803MEDLINEmedicineGeneral MedicineEpidermolysis bullosaDermatologybusinessmedicine.diseaseDermatologyInternal medicineRC31-1245Actas Dermo-Sifiliográficas
researchProduct